|Articles|May 10, 2000

Radiologix’s revenue rises

Revenue for radiology service networks operator Radiologix increased by 37% in the first quarter of 2000 (ending March 31). First-quarter revenue was $59.3 million compared to $43.2 million for the first quarter of 1999. Net income increased 5% to $4.1

Revenue for radiology service networks operator Radiologix increased by 37% in the first quarter of 2000 (ending March 31). First-quarter revenue was $59.3 million compared to $43.2 million for the first quarter of 1999. Net income increased 5% to $4.1 million in the first quarter of 2000, compared to $3.9 million in the first quarter of 1999.

Radiologix gains most of its revenue from service fees associated with the production and management of diagnostic imaging, including MR, ultrasound, CT, mammography, nuclear medicine and PET, along with general radiography and fluoroscopy. The company’s freestanding radiology centers provide services that have been outsourced by hospitals.

Related to this article

Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Does kV Still Matter in Photon-Counting CT?
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
CT Radiation Dosing: Where Things Stand, Part 2
In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).